Tonix Pharmaceuticals (TNXP) Misses Q1 EPS by 17c

Tonix Pharmaceuticals (NASDAQ: TNXP) reported Q1 EPS of ($0.71), $0.17 worse than the analyst estimate of ($0.54).

For earnings history and earnings-related data on Tonix Pharmaceuticals (TNXP) click here.

You May Also Be Interested In

• Flowers Foods (FLO) Misses Q2 EPS by 3c; Offers Guidance
• Jefferies: 38% of Australian companies beat estimates this season
• Forbright Bank to sell branches and deposits to Trustar Bank